| Schedule of Accrued Liabilities |
Accrued liabilities in the Condensed Consolidated Balance Sheets consisted of the following: | | | | | | | | | | | | | October 1, 2021 | | December 31, 2020 | | (In thousands) | | Accrued compensation and related benefits | $ | 136,759 | | | $ | 98,455 | | | | | | | Accrued taxes | 53,614 | | | 57,286 | | | Accrued asbestos-related liability | 47,412 | | | 41,626 | | | Warranty liability - current portion | 17,594 | | | 15,543 | | | Accrued restructuring liability - current portion | 7,784 | | | 7,889 | | | Accrued third-party commissions | 30,352 | | | 25,480 | | | Customer advances and billings in excess of costs incurred | 30,707 | | | 36,737 | | | Lease liability - current portion | 35,857 | | | 39,695 | | | Accrued interest | 8,364 | | | 27,153 | | | Other | 120,189 | | | 104,469 | | | $ | 488,632 | | | $ | 454,333 | |
|
| Schedule of Product Warranty Liability |
The activity in the Company’s warranty liability consisted of the following: | | | | | | | | | | | | | Nine Months Ended | | October 1, 2021 | | October 2, 2020 | | (In thousands) | | Warranty liability, beginning of period | $ | 15,543 | | | $ | 15,528 | | | Accrued warranty expense | 7,262 | | | 5,613 | | | Changes in estimates related to pre-existing warranties | 1,401 | | | 1,108 | | | Cost of warranty service work performed | (6,716) | | | (7,003) | | | Acquisition-related liability | 1,092 | | | — | | | Foreign exchange translation effect | (277) | | | (255) | | Warranty liability, end of period (1) | $ | 18,305 | | | $ | 14,991 | |
(1) As of October 1, 2021, $17.6 million of the Company’s Warranty liability was included in Accrued expenses, whereas $0.7 million of the Company’s Warranty liability was included in Other liabilities on the Company’s Condensed Consolidated Balance Sheet.
|
| Schedule of Restructuring Reserve by Type of Cost |
A summary of the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Condensed Consolidated Balance Sheets is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Nine Months Ended October 1, 2021 | | Balance at Beginning of Period | | | | Provisions | | Payments | | Foreign Currency Translation | | Balance at End of Period(3) | | (In thousands) | | Restructuring and other related charges: | | | | | | | | | | | | | Fabrication Technology: | | | | | | | | | | | | Termination benefits(1) | $ | 5,336 | | | | | $ | 4,572 | | | $ | (4,611) | | | $ | (43) | | | $ | 5,254 | | Facility closure costs(2) | 591 | | | | | 5,186 | | | (5,555) | | | (18) | | | 204 | | | 5,927 | | | | | 9,758 | | | (10,166) | | | (61) | | | 5,458 | | Non-cash charges(2) | | | | | 1,033 | | | | | | | | | | | | | 10,791 | | | | | | | | | Medical Technology: | | | | | | | | | | | | Termination benefits(1) | 1,884 | | | | | 2,728 | | | (2,149) | | | (9) | | | 2,454 | | Facility closure costs and other(2) | 297 | | | | | 2,464 | | | (2,735) | | | — | | | 26 | | | 2,181 | | | | | 5,192 | | | (4,884) | | | (9) | | | 2,480 | | Non-cash charges(2) | | | | | — | | | | | | | | | | | | | 5,192 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total Colfax Corporation: | | | | | | | | | | | | | Total restructuring liability activity | $ | 8,108 | | | | | 14,950 | | | $ | (15,050) | | | $ | (70) | | | $ | 7,938 | | | Total Non-cash charges | | | | | 1,033 | | | | | | | | | | | | | $ | 15,983 | | | | | | | |
(1) Includes severance and other termination benefits, including outplacement services. (2) Includes the cost of relocating associates, relocating equipment and lease termination expense in connection with the closure of facilities. (3) As of October 1, 2021, $7.8 million of the Company’s restructuring liability was included in Accrued liabilities, whereas less than $0.2 million of the Company’s restructuring liability was included in Other liabilities.
|